Knight Therapeutics | GUD - Market Capitalization


Knight Therapeutics reported CAD1.21B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 6M 1000K Jun/2026
Aurora Cannabis CAD 318.09M 145.93M Nov/2026
Avita Medical AUD 127.11M 21.64M Jun/2026
Canopy Growth CAD 88.38M 494.19M Nov/2026
Cronos Group USD 2B 781.98M Nov/2026
Dianthus Therapeutics USD 2.46B 2.87B Nov/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
IQVIA Holdings USD 48.06B 3.81B Nov/2026
Moderna USD 99.14B 22.26B Nov/2026
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Organon & Co USD 3.55B 49.18M Nov/2026
Revvity USD 19.52B 2.61B Nov/2026
Tectonic Therapeutic USD 649M 69M Jun/2026
Viatris USD 22.53B 2.18B Nov/2026
Xeris Pharmaceuticals USD 1.44B 70M Nov/2026